Gut microbiota, a new frontier to understand traditional Chinese medicines

被引:288
作者
Feng, Wuwen [1 ]
Ao, Hui [1 ]
Peng, Cheng [1 ,2 ]
Yan, Dan [3 ]
机构
[1] Chengdu Univ Tradit Chinese Med, Sch Pharm, Chengdu, Sichuan, Peoples R China
[2] Chengdu Univ Tradit Chinese Med, Key Lab Characterist Chinese Med Resources Southw, Chengdu, Sichuan, Peoples R China
[3] Capital Med Univ, Beijing Shijitan Hosp, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Gut microbiota; Traditional Chinese medicine; Herbal medicine; Metabolomics; CHAIN FATTY-ACIDS; HUMAN INTESTINAL BACTERIA; PERSONALIZED MEDICINE; ORAL BIOAVAILABILITY; INDIGO-NATURALIS; BARRIER FUNCTION; DRUG DISCOVERY; HUANGQIN-TANG; LIVER-DISEASE; METABOLISM;
D O I
10.1016/j.phrs.2019.02.024
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
As an important component of complementary and alternative medicines, traditional Chinese medicines (TCM) are gaining more and more attentions around the world because of the powerful therapeutic effects and less side effects. However, there are still some doubts about TCM because of the questionable TCM theories and unclear biological active compounds. In recent years, gut microbiota has emerged as an important frontier to understand the development and progress of diseases. Together with this trend, an increasing number of studies have indicated that drug molecules can interact with gut microbiota after oral administration. In this context, more and more studies pertaining to TCM have paid attention to gut microbiota and have yield rich information for understanding TCM. After oral administration, TCM can interact with gut microbiota: (1) TCM can modulate the composition of gut microbiota; (2) TCM can modulate the metabolism of gut microbiota; (3) gut microbiota can transform TCM compounds. During the interactions, two types of metabolites can be produced: gut microbiota metabolites (of food and host origin) and gut microbiota transformed TCM compounds. In this review, we summarized the interactions between TCM and gut microbiota, and the pharmacological effects and features of metabolites produced during interactions between TCM and gut microbiota. Then, focusing on gut microbiota and metabolites, we summarized the aspects in which gut microbiota has facilitated our understanding of TCM. At the end of this review, the outlooks for further research of TCM and gut microbiota were also discussed.
引用
收藏
页码:176 / 191
页数:16
相关论文
共 192 条
[21]   Anti-inflammatory effects of Huangqin tang extract in mice on ulcerative colitis [J].
Chen, Peidong ;
Zhou, Xi ;
Zhang, Li ;
Shan, Mingqiu ;
Bao, Beihua ;
Cao, Yudan ;
Kang, An ;
Ding, Anwei .
JOURNAL OF ETHNOPHARMACOLOGY, 2015, 162 :207-214
[22]   Combined systems pharmacology and fecal metabonomics to study the biomarkers and therapeutic mechanism of type 2 diabetic nephropathy treated with Astragalus and Leech [J].
Chen, Ruiqun ;
Liao, Chengbin ;
Guo, Qian ;
Wu, Lirong ;
Zhang, Lei ;
Wang, Xiufeng .
RSC ADVANCES, 2018, 8 (48) :27448-27463
[23]   Bioavailability Study of Berberine and the Enhancing Effects of TPGS on Intestinal Absorption in Rats [J].
Chen, Wei ;
Miao, Yu-Qiang ;
Fan, Dong-Jiao ;
Yang, Shen-Shen ;
Lin, Xia ;
Meng, Ling-Kuo ;
Tang, Xing .
AAPS PHARMSCITECH, 2011, 12 (02) :705-711
[24]   Toward Evidence-Based Chinese Medicine: Status Quo, Opportunities and Challenges [J].
Chen, Yao-long ;
Zhao, Chen ;
Zhang, Li ;
Li, Bo ;
Wu, Chuan-hong ;
Mu, Wei ;
Wang, Jia-ying ;
Yang, Ke-hu ;
Li, You-ping ;
Chen, Chiehfeng ;
Wang, Yong-yan ;
Wang, Chen ;
Bian, Zhao-xiang ;
Shang, Hong-cai .
CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2018, 24 (03) :163-170
[25]   BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides [J].
Choi, Ran Joo ;
Roy, Anupom ;
Jung, Hee Jin ;
Ali, Md. Yousof ;
Min, Byung-Sun ;
Park, Chan Hum ;
Yokozawa, Takako ;
Fan, Tai-Ping ;
Choi, Jae Sue ;
Jung, Hyun Ah .
JOURNAL OF ETHNOPHARMACOLOGY, 2016, 190 :219-230
[26]   Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism [J].
Clayton, T. Andrew ;
Baker, David ;
Lindon, John C. ;
Everett, Jeremy R. ;
Nicholson, Jeremy K. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (34) :14728-14733
[27]  
Costea PI, 2018, NAT MICROBIOL, V3, P388, DOI [10.1038/s41564-018-0114-x, 10.1038/s41564-017-0072-8]
[28]   The role of gut microbiota in the modulation of drug action: a focus on some clinically significant issues [J].
Curro, Diego .
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (02) :171-183
[29]   Bile acid transporters [J].
Dawson, Paul A. ;
Lan, Tian ;
Rao, Anuradha .
JOURNAL OF LIPID RESEARCH, 2009, 50 (12) :2340-2357
[30]   High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome [J].
De Filippis, Francesca ;
Pellegrini, Nicoletta ;
Vannini, Lucia ;
Jeffery, Ian B. ;
La Storia, Antonietta ;
Laghi, Luca ;
Serrazanetti, Diana I. ;
Di Cagno, Raffaella ;
Ferrocino, Ilario ;
Lazzi, Camilla ;
Turroni, Silvia ;
Cocolin, Luca ;
Brigidi, Patrizia ;
Neviani, Erasmo ;
Gobbetti, Marco ;
O'Toole, Paul W. ;
Ercolini, Danilo .
GUT, 2016, 65 (11) :1812-1821